Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Any stock can be shorted or naked shorted if you go to the right brokerage house - not necessarily in the US, but in other countries USA OTC stocks can definitely be shorted.
I am not a daytrader and, as such, not concerned with the day to day PPS price fluctuations. I am here for the launch of 2 to 3 ART products or a buyout - whichever comes first. My average buy-in price since April/2012 has given my account a very respectable green number. Having said this, I guess what I am saying is that I am not really concerned with the perceived prediction of share prices.
Speaking only about ELTP and having followed this message board since 2012, it is an obvious observation that Nasrat and company have provided a mountain of positive verifiable DD as opposed to the detractors who have provided virtually nothing at all to support their opinions. I would like to give credit to the numerous posters who have provided valuable and verifiable info over the years I have been here.
I am going to go with what Nasrat has publicly stated to the shareholders and the public investment community. I know Nasrat's full name, his background, where he works, his work telephone number and on and on and on. Who should I believe here?
A lot of tests had been completed with the goal of defeating ELTP's ART and it could not be accomplished according to Nasrat.
"Just to give you a simple example on the in vitro test one sub part of this big picture and my staff Dr. LePree and four extra employees we hired, two support and two permanent in conjunction with that and then associates took nine months or eight months to execute on the FDA’s requirement of trying to mimic what a person who wants to abuse our product will do by using household items, using the acetone that the wife may have to remove her finger nails with acetone or using alcohol that somebody may have or even Coca Cola; 17 different household items and 1,600 samples later for us to finish one little sub part."
http://seekingalpha.com/article/2696615-elite-pharmaceuticals-eltp-ceo-nasrat-hakim-on-q2-2015-results-earnings-call-transcript?part=single
Yes, this particular user's preferred method was snorting. Other sources showed a liking to the snorting or intravenous route. Either way, using ELTP ART products would prevent the desired euphoric high.
Please read the message thread again.
http://www.bluelight.org/vb/threads/786369-Need-some-help-Oxycodone-10mg
"I prefer snorting but a bit less gets into the blood but does hit quicker."
The Oxycodone user's preferred method was snorting. ELTP's ART will prevent the euphoric high if the drug is used in this way. That has been proven in the previously conducted tests.
Yes, I am aware of that but is there anything available on the market now to prevent multiple oral dosing from resulting in a high. To my knowledge, there is nothing available to prevent this.
I found this message thread referencing the recreational use of Oxycodone. One of the posters on the thread was quoted as saying,"Be careful. We all started with just one dose and many of us never stopped." I guess this is but one example why ADT's are needed.
http://www.bluelight.org/vb/threads/786369-Need-some-help-Oxycodone-10mg
Good one. Yes, the statement that fortunes could have been made if sold at the peak (97 cents)is just fabricated BS.
How many shares actually sold when the price peaked at 97 cents?
I am anticipating the launch of SequestOx this summer or early fall.
Yes, and we have been through this time and time again. Its been shown why the NDA was not filed in 2014. Links have been provided as such. The problem here is that the delay prompted by the NDA is being deflected to Nasrat.
Hm, now who should I believe here? Nasrat, an insider with the company who knows better than anyone else as to what is what is going on, or other sources who do not have any concrete, credible info as to the business end of the company.
What are you talking about? There seems to be some confusion about message thread topics here. We were talking about the allegation that ELTP stated the NDA was ready to be filed and then it wasn't; not about whether the FDA or ELTP had stated an efficacy trial was needed or not. Please stay on topic here.
Nasrat has stated a number of times there is regular communication between ELTP and the FDA. So, in September/2014, the PR stated they were ready to file the ELI200 NDA. In November/2014, Nasrat updated the shareholders by stating they were now awaiting guidance from the FDA as to whether an efficacy trial was required. It would appear that sometime between September and November the FDA had amended its guidance with a warning that an additional trial may be required. This resulted in Nasrat waiting for the FDA's decision as to whether they would need a trial.
First of all, I have not seen the word "promise" anywhere in Nasrat's vocabulary when communicating with the shareholders. You do know that the FDA is prone to changing their mind when it comes to providing guidance. First, they don't need a trial then, on second thought, they do. It happened to another pharmaceutical company I know of. Nasrat has stated a number of times it is his mission to deliver ELI200 (SequestOx) to the market as soon as possible. He has everything to gain and nothing to lose by doing so. He does own 23% of ELTP.
I believe the info you are interpreting as a promise is referenced in a PR dated September 9/2014 and the more recent info I posted in the link is dated November 19/2014. Do you think in that period of time between September and November the FDA advised Nasrat of the possible efficacy trial requirement? Hence the reference to the trial during the CC on November 19.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=120827257
Yes, you are correct on that.
A savvy CEO would negotiate and consult with the FDA as to which trials would be necessary. This is exactly what he has done. It would be ludicrous to expect Nasrat to spend millions of dollars on trials which may not have been required. He made the right decision in waiting for guidance from the FDA as to how to proceed.
And again, Nasrat was waiting on guidance from the FDA. To the impatient people here, this is a way of life when investing in a pharmaceutical stock.
http://seekingalpha.com/article/2696615-elite-pharmaceuticals-eltp-ceo-nasrat-hakim-on-q2-2015-results-earnings-call-transcript?part=single
"And that is the subject that I have mentioned many, many times to everybody before. I am going by the letter of the law and we have done everything that we believe the law requires. The FDA keeps coming back that they may want to see an efficacy and that’s what we’re negotiating with them. If they do and as I’ve said I have anticipated that they may ask for it, [indiscernible] there are certain things I may or may not ask for. And if they do that is what I have said, they will delay us by a few month but they will not stop us because everything else we’ve done has been to their liking."
"Trust me we’re ready to file next month, but we are not in such rush to file with the FDA and they come back three or four months later. We really wanted to do this one little thing but it will take three four months and end up delaying this badly. So we are waiting for the FDA and they promise expedite things to give us a clarity on what’s acceptable and what -- I shouldn’t say what’s not acceptable because everything has been acceptable to them. It’s the fact that they have never seen any product like ours before and they may ask us for some enhancements or couple of extra things and I can just say to you guys and update you guys on it before and once they make that decision that really will set things in motion but it just are facts [ph] that will happen one after the other."
Nasrat stated he was waiting for guidance from the FDA as to whether an efficacy trial (PHIII) would be required. This is not a "short test".
All this shows is that there are a total of three companies (four if you include ELTP) that have submitted their NDA's. This info does not confirm there will be a total of six competitors nor does it indicate if the competitor's NDA's will be approved ahead of ELTP. So essentially there are three NDA's (no idea when they will be approved) and two have gone to commercial stage. Thanks for NOT proving there will be six competitors ahead of ELTP.
Speaking of names, I am still waiting for the six ADT competitors who are allegedly coming to market prior to ELTP. Can you help me out here?
I agree. He criticizes Nazrat for failing to complete goals (which he has not) and yet fails to follow through with his own declaration of "when you say you're going to do something, you do it." And yet he is still here. This is very hypocritical of somebody who does this.
The B/S I heard was that shares were going be sold last week - no more position in ELTP. I believe it was said, "If you say you are going to do something, you do it". Looks like to a failure to follow through.
Just more gross misinformation just like there will be six ADT competitors coming to market before ELTP. You never did provide those names.
Well if you pulled the info off the top of your head, just throw it out there. Let's have a peek.
It's just a comment; an opinion with nothing factual to back it up.
I know. It's a great feature but for some reason it won't bring up info that does not exist.
No it has not otherwise I would remember the info.
The message thread started in reference to annual salaries being paid to ELTP associates in shares and now you are switching to potential class action lawsuits by shareholders?
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=120625905
Okay, show me a verifiable example of an employee of a publicly traded company where this has happened. The comment would be considered to be frivolous without this proof.
You broached the subject of potential lawsuits so show me the proof.
The message I was implying is that I did my own DD. This only included info (complete with verifiable sources including links). I did not consider any sources to be valid without this feature. To anybody reading this message board and considering taking a position in ELTP, I would suggest you do the same thing.
I did not allow myself to be discouraged from investing in ELTP based on unfounded opinions and statements. And yes, I will continue to buy shares of ELTP.
Why would there be lawsuits when those ELTP associates AGREED to be paid in shares? Show me one verifiable example of an employee who sued their employer over the non-performance of their remuneration (shares).
For some time now, my ELTP account has been showing a six figure profit - well into the six figure green zone. When the share price hits $1.12, I will have made my first million profit. When this milestone hits, I will remind you of this momentous event.
I LMAO every time I see that "2 cents is coming" share price. Given the existing positive fundamentals in place, I know the longs will have the last laugh.
Yes, and its also the truth.
Like the one he was ready to file in 2014 and the FDA came back and said - wait a minute; we might require additional trial(s). We will get back to you on that.